Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

News Features

Top News in Policy & Practice: 2018

Todd Neale

December 28, 2018

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News VIVA 2018

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

L.A. McKeown

November 13, 2018

News Conference News AHA 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

Shelley Wood

November 11, 2018

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Conference News VIVA 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

L.A. McKeown

November 06, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

Presentation CDM 2018

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

Presenter: John R. Laird

October 12, 2018

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Caitlin E. Cox

October 05, 2018

Presentation TCT Abstracts Posters 2018

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Presenter: Aleksandra Kolarczyk-Haczyk1

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of efficacy and safety kaolin-based hemostatic pad vs standard, mechanical compression following transradial and transulnar access for elective coronary angiography and PCI

Presenter: Pawel Lewandowski

September 25, 2018

Presentation TCT 2018

PAD: Overview of Current Management Strategies - Can We Do Better?

Presenter: Wayne B. Batchelor, Aaron Horne, Jr., Foluso Fakorede

September 24, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

Advertisement

The Biggest News of 2018: TCTMD’s Top 10

Top News in Endovascular Therapy: 2018

Top News in Policy & Practice: 2018

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

TCTMD’s Top 10 Most Popular Stories for October 2018

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Comparison of efficacy and safety kaolin-based hemostatic pad vs standard, mechanical compression following transradial and transulnar access for elective coronary angiography and PCI

PAD: Overview of Current Management Strategies - Can We Do Better?

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content